Hinge Health, Inc. HNGE
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3,212.74% | 107.59% | 104.96% | 18.36% | -4,353.43% |
| Total Depreciation and Amortization | 151.95% | -15.10% | -5.96% | -7.60% | -1.99% |
| Total Amortization of Deferred Charges | 69.73% | 71.47% | 69.22% | 51.86% | 40.91% |
| Total Other Non-Cash Items | -48.19% | -96.26% | 610.89% | 781.54% | 14,333.60% |
| Change in Net Operating Assets | -57.63% | 250.11% | 9.56% | -12.13% | -168.08% |
| Cash from Operations | 39.08% | 401.42% | 774.78% | 66.65% | 35.52% |
| Capital Expenditure | -18,000.00% | 37.56% | -62.75% | -159.87% | 54.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 172.55% | 581.39% | 378.73% | -1,161.01% | 35.80% |
| Cash from Investing | -9.22% | 611.71% | 325.40% | -1,110.53% | 50.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -61.96% | -97.05% | 322.68% | 4,102.88% | 117,255.05% |
| Repurchase of Common Stock | -- | 86.03% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 88.67% | -47,207.20% |
| Cash from Financing | -23,123.73% | 59.66% | -2,849.71% | -3,306.64% | -81,345.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -397.16% | 294.02% | -76.26% | -262.20% | -390.13% |